We’re thrilled to share that we’ve welcomed another outstanding?member to the AVS team, Emma Hawkes, Catheter Engineer! Emma will be responsible for the technical development and process validation activities of the catheter platform that delivers pulsatile pressure waves that treat calcific arterial and valve disease. We’re so glad to have you on our team, Emma! ? #medtech #medicaldevices #IVLAmplified
Amplitude Vascular Systems
医疗设备制造业
Boston,Massachusetts 5,062 位关注者
AVS is a medical device company focused on safely and effectively treating severely calcified arterial disease.
关于我们
AVS is an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2018 by Hitinder Gurm, M.D., Interventional Cardiologist and Chief Clinical Officer at University of Michigan, and Robert Chisena, Ph.D., Chief Technical Officer at AVS. We are redefining interventional therapy for severely calcified lesions with our Pulse IVL System, which uses a novel pulsatile mechanism of action to shatter calcium and expand narrowed vessels, all with a single device. To learn more about pulsatile intravascular lithotripsy, visit www.avspulse.com.
- 网站
-
www.avspulse.com
Amplitude Vascular Systems的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 2-10 人
- 总部
- Boston,Massachusetts
- 类型
- 私人持股
- 创立
- 2020
地点
-
主要
451 D St
US,Massachusetts,Boston,02210
Amplitude Vascular Systems员工
动态
-
Robert Chisena, co-founder, Sean Gilligan, Chief Operations Officer, and Angie Volk, VP of Business Development, recently spoke?with Reed Miller from MedTech Strategist about the history of AVS, how the Pulse IVL??System works, and what sets our technology apart from competitors. Read the full piece here:?https://lnkd.in/e9GMVxW2 #medicaldevices #medtech #IVLAmplified
-
We’re delighted to share that Anthony Christopher has joined our team as a Clinical Field Specialist! Anthony has over 25 years of combined experience in clinical support, clinical research, medical sales, and patient care. He will play a critical role in planning and executing clinical trials and research studies for our Pulse IVL? System. Welcome to the team, Anthony! #medicaldevices #medtech
-
Congratulations?to OhioHealth for being the third site to enroll in the POWER PAD II US IDE with the Pulse IVL System. Dr. Michael Jolly completed the case at Riverside Methodist Hospital in Columbus, OH. We look forward to partnering with their amazing team to improve outcomes for patients with severe calcified disease! #medicaldevices #IVLAmplified
-
Exciting news! AVS was awarded Gold in the “Startup Achievement of the Year” category of the Globee Awards.?We’re honored to be recognized for our commitment to improving the lives of patients with calcific peripheral artery disease. ? Learn more about Pulse IVL here: https://avspulse.com ? #IVLAmplified #medtech?
-
We're #hiring a new Sr. Process Engineer in Greater Boston. Apply today or share this post with your network.
-
Our new and improved website has launched! Ready to learn more about AVS and our amazing Pulse IVL technology? Check it out today: https://www.avspulse.com/ #IVLAmplified #medicaldevices
-
Congratulations to Advanced Heart And Vein Center in Denver, CO for being the second site to enroll in the POWER PAD II US IDE with the Pulse IVL System. Dr. Qaisar Khan completed the case and Dr. Ehrin Armstrong is the site Principal Investigator. We look forward to partnering with their amazing team to improve outcomes for patients with severe calcified disease! #IVLAmplified #medicaldevices
-
It’s an exciting day at AVS as we’ve enrolled the very first patient in our POWER PAD II US Pivotal trial with our Pulse IVL therapy!?Dr. Nicolas W. Shammas conducted the case at?UnityPoint Health Trinity Hospital in Bettendorf, Iowa.? ? “AVS is one of the first companies to conduct a peripheral intravascular lithotripsy pivotal IDE trial in the U.S., and this patient is the first of many U.S. patients who will benefit from our innovative technology.” - Elizabeth Galle, VP Clinical Affairs at AVS? ? Learn more about our POWER PAD II clinical study: https://lnkd.in/eJ5cWk9C ? #IVLAmplified #medtech #medicaldevices
-
Today, there is an escalated appetite to address intravascular lithotripsy,?a procedure utilized to break calcified lesions in arteries throughout the body.? ? We’re proud to be one of several companies committed to improving the lives of patients with calcific peripheral artery disease, and it is great to be recognized by Medical Device Network as one of the novel technologies that will address areas of opportunity in the current market to improve patient outcomes. ? Learn?more about the POWER PAD II clinical study, which will evaluate the safety and efficacy of our Pulse IVL System in up to 120 patients, in this recent Medical Device Network article:?https://lnkd.in/ezxD9sHK? ? #medtech #medicaldevices #IVLAmplified?
Intravascular lithotripsy – a clinical trial snapshot
medicaldevice-network.com